These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 26864938)

  • 1. FGF23 from bench to bedside.
    Kovesdy CP; Quarles LD
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1168-74. PubMed ID: 26864938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fibroblast growth factor-23 in cardiorenal syndrome.
    Kovesdy CP; Quarles LD
    Nephron Clin Pract; 2013; 123(3-4):194-201. PubMed ID: 23942553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23 and Klotho in chronic kidney disease.
    Olauson H; Larsson TE
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):397-404. PubMed ID: 23666415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
    PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].
    Lacroix JS; Urena-Torres P
    Nephrol Ther; 2020 Mar; 16(2):83-92. PubMed ID: 31843356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor-23: what we know, what we don't know, and what we need to know.
    Kovesdy CP; Quarles LD
    Nephrol Dial Transplant; 2013 Sep; 28(9):2228-36. PubMed ID: 23625971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease.
    Kondo Y; Komaba H; Fukagawa M
    Expert Rev Mol Diagn; 2020 Jul; 20(7):715-724. PubMed ID: 32513031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrarenal effects of FGF23.
    Haffner D; Leifheit-Nestler M
    Pediatr Nephrol; 2017 May; 32(5):753-765. PubMed ID: 27704252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on fibroblast growth factor 23 in chronic kidney disease.
    Wolf M
    Kidney Int; 2012 Oct; 82(7):737-47. PubMed ID: 22622492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
    Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
    Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
    Gan L; Zhou Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New markers of cardio-renal links in chronic kidney disease].
    Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
    Ter Arkh; 2013; 85(6):17-24. PubMed ID: 23866594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.